| FENNEC PHARMACEUT. |
| Kanada |
| Gesundheit |
| CA31447P1009 / A12A5F |
| RV41 (Frankfurt) / FENC (NASDAQ) |
| FRA:RV41, ETR:RV41, RV41:GR, NASDAQ:FENC |
| - |
| https://fennecpharma.com/ |
|
Fennec Pharmaceuticals Inc. is a clinical-stage bi..
>Volltext.. |
| 193.24 Mio. EUR |
| 192.72 Mio. EUR |
| 29.53 Mio. EUR |
| -8.47 Mio. EUR |
| -10.24 Mio. EUR |
| -0.37 EUR |
| 15.68 Mio. EUR |
| 16.21 Mio. EUR |
| -10.14 Mio. EUR |
| 2.22 |
| -35.75% |
| -514.24% |
| - |
| - |
| - |
| FENNEC |
| 08.11.25 |